THE IMPACT OF FAMILY HISTORY ON OVARIAN-CANCER RISK - THE UTAH POPULATION DATABASE

被引:43
作者
KERBER, RA
SLATTERY, ML
机构
关键词
D O I
10.1001/archinte.155.9.905
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate the relative risks and population attributable risks of ovarian cancer associated with family histories of cancer at several sites. Methods: A matched case-control analytic study (662 cases, 2647 controls), employing the Utah Population Database, a genealogy of approximately 1 million individuals linked to cancer incidence data from the Utah Cancer Registry. Family history was assessed using kinship order and a kinship-weighted familial standardized incidence ratio statistic. Results: Family histories of ovarian, uterine, breast, and pancreatic cancer were significantly associated with increased risk of ovarian cancer. The relative risk of ovarian cancer was 4.31 (95% confidence interval [CI], 2.35 to 7.90) for women with a first-degree: relative with ovarian cancer, 2.12 (95% CI, 1.19 to 3.78) for women with an affected second-degree relative, and 1.48 (95% CI, 0.98 to 2.24) for women with an affected third-degree relative. The odds ratio (OR) was 2.06 (95% CI, 1.44 to 2.93) for those with the highest familial standardized incidence ratio. No age differences were observed between cases with and without a family history of ovarian cancer. There was substantial heterogeneity of family history effects by cell type. Increased parity was not protective among women with a strong family history of cancer at the sites studied (OR, 1.11; 95% CI, 0.38 to 3.26), although it was protective among women without a family history of these cancers (OR, 0.29; 95% CI, 0.11 to 0.62). Conclusions: The risk of ovarian cancer was substantially increased among women with family histories of ovarian, uterine, pancreatic, and, to a lesser degree, breast cancer. Among women with family histories of any of these cancers, the risk of ovarian cancer is not diminished by high parity.
引用
收藏
页码:905 / 912
页数:8
相关论文
共 57 条
[1]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[2]  
AMOS CI, 1993, CANCER-AM CANCER SOC, V71, P566
[3]   AGE AT ONSET FOR FAMILIAL EPITHELIAL OVARIAN-CANCER [J].
AMOS, CI ;
SHAW, GL ;
TUCKER, MA ;
HARTGE, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (14) :1896-1899
[4]  
[Anonymous], 1976, INT CLASSIFICATION D
[5]  
Berek Jonathan S., 1993, P1659
[6]   ONCOGENESIS IN OVARIAN-CANCER [J].
BORRESEN, AL .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 :25-30
[7]  
Breslow NE, 1987, STAT METHODS CANC RE, P2
[8]   ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK-FACTORS USING CASE-CONTROL DATA [J].
BRUZZI, P ;
GREEN, SB ;
BYAR, DP ;
BRINTON, LA ;
SCHAIRER, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 122 (05) :904-913
[9]  
BYERS T, 1983, JNCI-J NATL CANCER I, V71, P681
[10]  
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development, 1987, N Engl J Med, V316, P650